166 related articles for article (PubMed ID: 7543452)
21. [Vasodilator effect of nitric oxide is a necessary counter-regulation in the spontaneously hypertensive rat].
Arnal JF; Battle T; Ménard J; Michel JB
Arch Mal Coeur Vaiss; 1993 Aug; 86(8):1193-6. PubMed ID: 7510467
[TBL] [Abstract][Full Text] [Related]
22. Renoprotective effects of omapatrilat are mediated partially by bradykinin.
Zhou X; Ono H; Ono Y; Frohlich ED
Am J Nephrol; 2003; 23(4):214-21. PubMed ID: 12789027
[TBL] [Abstract][Full Text] [Related]
23. Time dependence of effect of nitric oxide synthase inhibition on cerebral ischemic damage.
Zhang F; Xu S; Iadecola C
J Cereb Blood Flow Metab; 1995 Jul; 15(4):595-601. PubMed ID: 7540621
[TBL] [Abstract][Full Text] [Related]
24. [Study on roles of L-arginine to nitric oxide pathway for the cardiovascular control: assessment with a new model of hypertension produced by the chronic administration of nitric oxide synthase inhibitor].
Shudo H
Hokkaido Igaku Zasshi; 1994 Jul; 69(4):967-77. PubMed ID: 7525439
[TBL] [Abstract][Full Text] [Related]
25. Differential renal response to Nomega-nitro-L-arginine methyl ester and L-arginine in rats with hypertensive or diabetic nephropathy.
Erley CM; Heyne N; Friedrich B; Schmidt T; Strobel U; Wehrmann M; Osswald H
J Cardiovasc Pharmacol; 2002 Nov; 40(5):780-8. PubMed ID: 12409987
[TBL] [Abstract][Full Text] [Related]
26. Renoprotective effects of melatonin in young spontaneously hypertensive rats with L-NAME.
Cheng MC; Wu TH; Huang LT; Tain YL
Pediatr Neonatol; 2014 Jun; 55(3):189-95. PubMed ID: 24268813
[TBL] [Abstract][Full Text] [Related]
27. Ramipril prevents the detrimental sequels of chronic NO synthase inhibition in rats: hypertension, cardiac hypertrophy and renal insufficiency.
Hropot M; Grötsch H; Klaus E; Langer KH; Linz W; Wiemer G; Schölkens BA
Naunyn Schmiedebergs Arch Pharmacol; 1994 Dec; 350(6):646-52. PubMed ID: 7535899
[TBL] [Abstract][Full Text] [Related]
28. Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension.
Ribeiro MO; Antunes E; de Nucci G; Lovisolo SM; Zatz R
Hypertension; 1992 Sep; 20(3):298-303. PubMed ID: 1516948
[TBL] [Abstract][Full Text] [Related]
29. Comparison of effect of endothelin antagonism and angiotensin-converting enzyme inhibition on blood pressure and vascular structure in spontaneously hypertensive rats treated with N omega-nitro-L-arginine methyl ester. Correlation with topography of vascular endothelin-1 gene expression.
Li JS; Deng LY; Grove K; Deschepper CF; Schiffrin EL
Hypertension; 1996 Aug; 28(2):188-95. PubMed ID: 8707380
[TBL] [Abstract][Full Text] [Related]
30. Nitric oxide inhibition accelerates hypertension and induces perivascular inflammation in rats.
Hsieh NK; Wang JY; Liu JC; Wang SD; Chen HI
Clin Exp Pharmacol Physiol; 2004 Apr; 31(4):212-8. PubMed ID: 15053816
[TBL] [Abstract][Full Text] [Related]
31. Nitric oxide synthase inhibition and acute renal ischemia: effect on systemic hemodynamics and mortality.
Atanasova I; Burke TJ; McMurtry IF; Schrier RW
Ren Fail; 1995 Jul; 17(4):389-403. PubMed ID: 7569111
[TBL] [Abstract][Full Text] [Related]
32. Role of endothelium-derived nitric oxide in control of renal microvasculature in aging male rats.
Reckelhoff JF; Manning RD
Am J Physiol; 1993 Nov; 265(5 Pt 2):R1126-31. PubMed ID: 8238614
[TBL] [Abstract][Full Text] [Related]
33. Genetic variants on rat chromosome 8 exhibit profound effects on hypertension severity and survival during nitric oxide inhibition in spontaneously hypertensive rats.
Schulz A; Schütten-Faber S; Schulte L; Unland J; Kossmehl P; Kreutz R
Am J Hypertens; 2014 Mar; 27(3):294-8. PubMed ID: 24363279
[TBL] [Abstract][Full Text] [Related]
34. Effects of ANG-converting enzyme and alpha 1-adrenoceptor inhibition on intrarenal hemodynamics in SHR.
Numabe A; Komatsu K; Frohlich ED
Am J Physiol; 1994 May; 266(5 Pt 2):R1437-42. PubMed ID: 8203617
[TBL] [Abstract][Full Text] [Related]
35. Assessment of renal dopaminergic system activity in the nitric oxide-deprived hypertensive rat model.
Soares-da-Silva P; Pestana M; Vieira-Coelho MA; Fernandes MH; Albino-Teixeira A
Br J Pharmacol; 1995 Apr; 114(7):1403-13. PubMed ID: 7541690
[TBL] [Abstract][Full Text] [Related]
36. Nitric oxide influences blood flow distribution in renovascular hypertension.
Sigmon DH; Beierwaltes WH
Hypertension; 1994 Jan; 23(1 Suppl):I34-9. PubMed ID: 8282373
[TBL] [Abstract][Full Text] [Related]
37. Fasudil, a Rho-kinase inhibitor, reverses L-NAME exacerbated severe nephrosclerosis in spontaneously hypertensive rats.
Koshikawa S; Nishikimi T; Inaba C; Akimoto K; Matsuoka H
J Hypertens; 2008 Sep; 26(9):1837-48. PubMed ID: 18698220
[TBL] [Abstract][Full Text] [Related]
38. Enhanced superoxide activity modulates renal function in NO-deficient hypertensive rats.
Kopkan L; Majid DS
Hypertension; 2006 Mar; 47(3):568-72. PubMed ID: 16401762
[TBL] [Abstract][Full Text] [Related]
39. Effects of long-term losartan and L-arginine treatment on haemodynamics, glomerular filtration, and SOD activity in spontaneously hypertensive rats.
Miloradović Z; Jovović D; Mihailović-Stanojević N; Milanović JG; Milanović S
Can J Physiol Pharmacol; 2008 Apr; 86(4):210-4. PubMed ID: 18418431
[TBL] [Abstract][Full Text] [Related]
40. Modulation of glomerular arteriolar tone by nitric oxide synthase inhibitors.
Edwards RM; Trizna W
J Am Soc Nephrol; 1993 Nov; 4(5):1127-32. PubMed ID: 7508276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
